2023年8月18日全网发布的《不吃主食会酮酸中毒,危及生命吗》：肥胖、糖前和2糖准备低碳生酮的人最害怕听到这样忠告：不吃主食会酮酸中毒，太危险？事实真的如此吗？深度解读背后逻辑，深挖中外科学证据。低碳水、生酮饮食也许不适合每个人，但也适许多人，请大家理性对待，科学规划自己的健康之路。最后，低碳水饮食一定要避免某种药物，因为这会提高酮酸中毒的风险。请生酮低碳人士收藏。
视频片段：
- 张东铭医生：什么是糖尿病酮症酸中毒（有来医生）
m.baidu.com/bh/m/detail/sv_3216568881940144502
- Ketoacidosis on keto – is it really a thing? Dr Paul Mason 12 Apr 2019
- Dr Stephen Phinney on Nutritional Ketosis and Ketogenic Diets Part 1-2018
virtahealth.com
- Ketones and weight loss
diabetes.co.uk/diabetes-and-ketones.html
- Dr. Sarah Hallberg on ketosis vs. ketoacidosis Sept 2018
virtahealth.com
涉及的文献：
- Hyperglycemic Crises in Adult Patients with Diabetes
A consensus statement from the American Diabetes Association
DIABETES CARE, VOLUME 29, NUMBER 12, DECEMBER 2006
- 葛均波，徐永健，王辰主编.《内科学》第9版一北京:人民 卫生出版社， 2018
P745第22章第二节 糖尿病酮症酸中毒
- The Management of Diabetic Ketoacidosis in Adults*
- Stephen D. Phinney Jeff S. Volek. The Art and Science of Low Carbohydrate Living: An Expert Guide to Making the Life-Saving Benefits of Carbohydrate Restriction Sustainable and Enjoyable
Beyond Obesity, LLC 2021 ISBN-13 978-0983490708
- Virta Health 1st Year Clinic Report:
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study
Diabetes Therapy volume 9, pages583–612 (2018)
- Virta Health 2nd Year Clinic Report:
Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial
Front. Endocrinol., 05 June 2019
Sec. Clinical Diabetes
Volume 10 – 2019 | https://doi.org/10.3389/fendo.2019.00348
- 中国2型糖尿病防治指南(2020年版)
第十章 高血糖的药物治疗 一 口服降糖药物 (七) SGLT2i
- UCLA Health
https://www.uclahealth.org/news/ketosis-ketoacidosis-sound-similar-but-not-the-same-thing
December 17, 2021
- Ketoacidosis Crisis in USA
Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
https://www.ncbi.nlm.nih.gov/books/NBK279052/
Last Update: May 9, 2021
- An Update on the Incidence and Burden of Diabetic Ketoacidosis in the U.S.
Diabetes Care 2020;43(12):e196–e197
https://doi.org/10.2337/dc20-1258
- 关于SGLT2 增加酮酸中毒风险的文献
Douros A, Lix LM, Fralick M, Dell’Aniello S, Shah BR, Ronksley PE, Tremblay É, Hu N, Alessi-Severini S, Fisher A, Bugden SC, Ernst P, Filion KB; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study. Ann Intern Med. 2020 Sep 15;173(6):417-425. doi: 10.7326/M20-0289. Epub 2020 Jul 28. PMID: 32716707.
U.S. Food and Drug Administration (FDA). 2022. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections, FDA Drug Safety Communication. Available: https://www.fda.gov/drugs/drug-safety-and-availability/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious#:~:text=SGLT2%20inhibitors%20are%20not%20FDA,to%20evaluate%20this%20safety%20issue.
- 儿童研究
Long-term outcomes of children treated with the ketogenic diet in the past
*Amisha Patel, yPaula L. Pyzik, zZahava Turner, yJames E. Rubenstein, and yEric H. Kossoff
Epilepsia, 51(7):1277–1282, 2010
doi: 10.1111/j.1528-1167.2009.02488.x
